About
OrganOx is a medical technology company based in Oxford, England, founded in 2008 as a spin-out from the University of Oxford. The company specializes in advanced organ preservation devices using Normothermic Machine Perfusion (NMP) technology. Its flagship product, the *metra* device, preserves donor livers by mimicking the human body's natural environment, allowing organs to remain functional outside the body for extended periods. The *metra* device enables real-time assessment of organ viability, which helps reduce organ discard rates and increases the number of usable donor organs. This technology allows for more efficient scheduling of transplant surgeries, improving patient outcomes. OrganOx's products have received regulatory approvals in multiple regions, including the US, EU, UK, Australia, and Canada, and have been utilized in over 6,000 liver transplants worldwide. In 2025, OrganOx was acquired by Terumo Corporation for $1.5 billion, highlighting its leadership in organ preservation technology.
Technologies
Keywords
Company Information
-
Employees 210
-
Founded 2008
-
Annual Revenue $74000000
-
Total Funding $184594411
Location
John Smith Drive, Oxford, England, United Kingdom, OX4 2WB